HHS urged to give all providers more time to spend COVID-19 relief funds

Jun 23, 2021 - 03:35 PM

AHA yesterday urged the Department of Health and Human Services to allow all health care providers to use their COVID-19 Provider Relief Fund payments until June 30, 2022, or the end of the COVID-19 public health emergency, whichever is later. HHS recently extended the deadline to use PRF funds, but only for providers who received their funds after June 30, 2020. While AHA appreciates the partial extension, it said hospitals and health systems continue to incur expenses related to COVID-19 cases and hospitalizations.

“Hospitals and health systems must be able to apply their PRF money toward these costs, which they will undoubtedly continue to incur beyond June 30 and through the end of the PHE, without regard to when the funds were originally received,” AHA wrote.
 

Related News Articles

Headline
HHS announces efforts to improve long COVID care 
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
FDA issues serious recall for electric wheelchair joysticks
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
CDC releases 2025-26 respiratory disease season outlook
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
OSHA extends comment period on proposal removing remaining COVID-19 emergency temporary standard requirements
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…
Headline
CDC says COVID-19 cases growing or likely growing in 45 states 
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
FDA announces recall of cefazolin by Sandoz for mislabeling
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…